Abstract
Percutaneous and surgical ablation procedures are flourishing, in large part because of the relative paucity and the acceptability of complications. However, serious and fatal complications have occurred, albeit rarely, with ablation. This chapter identifies those complications, describes their underlying cause, and, when possible, discusses strategies to avoid them.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bret PM, Sente JM, Bretagnolle M, et al. Ultrasonically guided fine-needle biopsy in focal intrahepatic lesions: 6 years experience. Can Assoc Radiol J 1986;37:5–8.
Di Stasi M, Buscarini L, Livraghi T, et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma. A multicenter survey of evaluation practices and complication rates. Scand J Gastroenterol 1997;32:1168–1173.
Livraghi T, Giorgio A, Marin G, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995;197:101–108.
Giorgio A, Tarantino L, de Stefano G, et al. Complications after interventional sonography of focal liver lesions. A 22-year single-center experience. J Ultrasound Med 2003;22:193–205.
Livraghi T, Vettori C, Torzilli G, et al. Long-term results of single-session percutaneous ethanol injection in patients with large hepatocellular carcinoma. Cancer 1998;83:48–57.
Boucher E, Carsin A, Raoul JL, et al. Massive hepatic necrosis secondary to treatment of hepatocellular carcinoma by percutaneous alcoholization. Gastroenterol Clin Biol 199;22:459–461.
de Baère T, Roche A, Amenabar JM, et al. Liver abscess formation after local treatment of liver tumors. Hepatology 1996;23:1436–1440.
Miki K, Makuuchi M, Takayama T, et al. Peritoneal seeding of hepatocellular carcinoma after ethanol injection therapy. Hepato-Gastroenterology 2000;47:1428–1430.
Ishii H, Okada S, Okusaka T, et al. Needle tract implantation of hepatocellular carcinoma after percutaneous ethanol injection. Cancer 1998;82:1638–1642.
Casella G, Cacopardo E, Rovere G, et al. Cutaneous seeding after ultrasound-guided percutaneous ethanol injection for treatment of hepatocellular carcinoma. J Clin Ultrasound 2001;29:354–358.
Matsumata T, Okamoto M, Ishikawa H, et al. Necrosis of the hepatocellular carcinoma nodule can aggravate metastasis. Nippon Geka Gakkai Zasshi 1998;99:197–200.
Elgindy N, Lindolm H, Gunven P. High-dose percutaneous ethanol injection therapy of liver tumors. Patient acceptance and complications. Acta Radiologica 2000;41:458–463.
Seki S, Kitada T, Otogawa K, et al. Gastric ulcer as a rare complication of percutaneous ethanol injection for hepatocellular carcinoma. Am J Gasteroenterol 2002;97:770–771.
Isobe H, Sakamoto S, Nawata H. Splenic abscess as a complication of percutaneous ethanol injection therapy for hepatocellular carcinoma. J Clin Gastroenterol 1992;15:167–179.
Komorowski J, Kuzdak K, Pomorski L, et al. Percutaneous ethanol injection in treatment of benign nonfunctional and hyperfunctional thyroid nodules. Cytobios 1998;95:143–150.
Angelini F, Nacamulli D, De Vido D, et al. Treatment of hot thyroid nodule with percutaneous ethanol injection: indications, complications, and prognostic factors. Radiologia Medica 1996;91:774–780.
Livraghi T, Solbiati L, Meloni MF, et al. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 2003;226:441–451.
de Baère T, Risse O, Kuoch V, et al. Adverse events during radiofrequency treatment of 582 hepatic tumors. AJR. Am J Roentgenol 2003;181:695–700.
Schmidt-Mutter C, Breining T, Gangi A, et al. Fatal bile pulmonary embolism after radiofrequency treatment of a hepatocellular carcinoma. Surg Endosc 2003;17:2028–2031.
de Sio I, Castellano L, De Girolarno V, et al. Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma. Hepatology 2001;34:609–610.
Llovet JM, Vilana R, Bru C, et al. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 2001;33:1124–1129.
Chapman W, Debelak J, Pinson CW, et al. Hepatic cryoablation, but not radiofrequency ablation, results in lung inflammation. Ann Surg 2000;231:752–761.
Seifert J, France M, Zhao J, et al. Large volume hepatic freezing: association with significant release of the cytokines interleukin-6 and tumor necrosis factor-alpha in a rat model. World J Surg 2002;26:1333–1341.
Yamamoto T, Kubo S, Hirohashi K, et al. Secondary hemocholecyst after radiofrequency ablation therapy for hepatocellular carcinoma. J Gastroenterol 2003;28:399–403.
Verhoeven B, Haagsma E, Appeltans B, et al. Hyperkalaemia after radiofrequency ablation of hepatocellular carcinoma. Eur J Gastroenterol Hepatol 2002;14:1023–1024.
Onik G, Onik C, Medary I, et al. Life-threatening hypertensive crises in two patients undergoing hepatic radiofrequency ablation. AJR Am J Roentegenol 2003;181:495–497.
Napier D, Dodd G, Hubbard L, et al. Post-ablation syndrome following radiofrequency thermal ablation of liver tumors. Presented at SGR 29th Annual Meeting. March 12, 2000. Kauai, Hawaii.
Goldberg SN, Solbiati L, Halpern EF, et al. Variables affecting proper system grounding for radiofrequency ablation in an animal model. J Vasc Interv Radiol 2000;11:1069–1075.
King J, Glenn D, Clark W, et al. Percutaneous radiofrequency ablation of pulmonary metastases in patients with colorectal cancer. Br J Surg 2004;91:217–223.
vanSonnenberg E, Shanker S, Morrison PR, et al. Radiofrequency ablation of thoracic lesions: part II initial clinical experience-technical and multidisciplinary considerations in 30 patients. AJR 2005;184:381–390.
Dupuy D, Mayo-Smith W, DiPetrillo T, et al. Clinical experience of pulmonary radiofrequency ablation in 27 patients. Radiological Society of North America Proceedings, Chicago, November 2001;Abstract 389.
Nishida T, Inoue K, Kawata Y, et al. Percutaneous radiofrequency ablation of lung neoplasms: a minimally invasive strategy for inoperable patients. J Am Coll Surg 2002;195:426–430.
Sewell P Jr, Jackson M, Vance R, et al. Assessing radiofrequency ablation of non-small cell lung cancer with positron emission tomography (PET). Radiology 2000;217(Suppl):334.
Lee J, Jin K, Kim C, et al. Percutaneous radiofrequency ablation for inoperable lung malignancies: a preliminary report. Radiological Society of North America Proceedings, Chicago, November 2001;Abstract 390.
Vaughn C, Mychaskiw G II, Sewell P. Massive hemorrhage during radiofrequency ablation of a pulmonary neoplasm. Anesth Analg 2002;94:1149–1151.
Gervais D, McGovern F, Wood B, et al. Radio-frequency ablation of renal cell carcinoma: early clinical experience. Radiology 2000;217:665–672.
Pavlovich C, McClellan W, Choyke P, et al. Percutaneous radio frequency ablation of small renal tumors: initial results. J Urol 2002;167:10–15.
de Baere T, Kuoch V, Smayra T, et al. Radio frequency ablation of renal cell carcinoma: preliminary clinical experience. J Urol 2002;167:1961–1964.
Su L, Jarrett T, Chan D, et al. Percutaneous computed tomography-guided radiofrequency ablation of renal masses in high surgical risk patients: preliminary results. Urology 2003;61(Suppl 4A):26–33.
Mayo-Smith W, Dupuy D, Parikh P, et al. Imaging-guided percutaneous radiofrequency ablation of solid renal masses: techniques and outcomes of 38 treatment sessions in 32 consecutive patients. AJR Am J Roentgenol 2003;180:1503–1508.
Johnson D, Saboorian M, Duchene D, et al. Nephrectomy after radiofrequency ablation-induced ureteropelvic junction obstruction: potential complication and long-term assessment of ablation adequacy. Urology 2003;62:351–352.
Goetz M, Callstrom M, Charboneau J, et al. Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study. J Clin Oncol 2004;22:300–306.
Ibrahim D, Ho E, Scherl SA, et al. Newborn with an open posterior hip dislocation and sciatic nerve injury after intrauterine radiofrequency ablation of a sacrococcygeal teratoma. J Pediatr Surg 2003;38:248–250.
Wood B, Abraham J, Hvizda J, et al. Radiofrequency ablation of adrenal tumors and adreno-cortical carcinoma metastases. Cancer 2003;97:554–560.
Mayo-Smith W, Dupuy D. Adrenal neoplasms: CT-guided radiofrequency ablation-preliminary results. Radiology 2004;231:225–230.
Izzo F, Thomas R, Delrio P, et al. Radiofrequency ablation in patients with primary breast carcinoma: a pilot study in 26 patients. Cancer 2001;92:2036–2044.
Burak W, Agnese D, Povoski S, et al. Radiofrequency ablation of invasive breast carcinoma followed by delayed surgical excision. Cancer 2003;98:1369–1375.
Hayashi A, Silver S, van der Westhuizen N, et al. Treatment of invasive breast carcinoma with ultrasound-guided radiofrequency ablation. Am J Surg 2003;185:429–435.
Fornage B, Sneige N, Ross M, et al. Small (≤2cm) breast cancer treated with US-guided radiofrequency ablation: feasibility study. Radiology 2004;231:215–224.
Adam R, Hagopian E, Linhares M, et al. A comparison of percutaneous cryosurgery and percutaneous radiofrequency for unresectable hepatic malignancies. Arch Surg 2002;137:1332–1339.
Tait LS, Yong SM, Cuschieri A. Laparoscopic in situ ablation of liver cancer with cryotherapy and radiofrequency ablation. Br J Surg 2002;89:1613–1619.
Lezoche E, Paganini A, Feliciotti F, et al. Ultrasound-guided laparoscopic cryoablation of hepatic tumors: preliminary report. World J Surg 1998;22:829–836.
Sarantou T, Bilchik A, Ramming K. Complications of hepatic cryosurgery. Semin Surg Oncol 1998;14:156–162.
Sohn R, Carlin A, Steffes C, et al. The extent of cryosurgery increases the complication rate after hepatic cryoablation. Am Surg 2003;69:317–322.
Crews K, Kuhn J, McCarty T, et al. Cryosurgical ablation of hepatic tumors. Am J Surg 1997;174:614–617.
Seifert J, Morris D. World survey on the complications of hepatic and prostate cryotherapy. World J Surg 1999;23:109–114.
Cha C, Lee F, Rikkers L, et al. Rationale for the combination of cryoablation with surgical resection of hepatic tumors. J Gastrointest Surg 2001;5:206–213.
Onik G, Atkinson D, Zemel R, et al. Cryosurgery of liver cancer. Semin Surg Oncol 1993;9:309–317.
Pearson AS, Izzo F, Fleming RY, et al. Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am J Surg 1999;178:592–599.
Morris D, Ross W, Iqbal J, et al. Cryoablation of hepatic malignancy: an evaluation of tumor marker data and survival in 110 patients. Gastrointest Cancer 1996;1:247–251.
Seifert J, Stewart G, Hewitt P, et al. Interleukin-6 and tumor necrosis factor-alpha levels following hepatic cryotherapy: association with volume and duration of freezing. World J Surg 1999;23:1019–1026.
Yeh K, Fortunato L, Hoffman J, et al. Cryosurgical ablation of hepatic metastases from colorectal carcinomas. Am Surg 1997;63:63–68.
Weaver ML, Ashton J, Zemel R. Treatment of colorectal liver metastases by cryotherapy. Semin Surg Oncol 1998;14:163–170.
Silverstein JC, Staren E, Velasco J. Thermal bile duct protection during liver cryoablation. J Surg Oncol 1997;64:163–164.
Weaver ML, Atkinson D, Zemel R. Hepatic cryosurgery in treating colorectal metastases. Cancer 1995;76:210–214.
Cozzi P, Stewart G, Morris D. Thrombocytopenia after hepatic cryotherapy for colorectal metastases: correlates with hepatocellular injury. World J Surg 1994;18:774–777.
Gonder M, Soanes W, Shulman S. Cryosurgical treatment of the prostate. Invest Urol 1966;3:372–378.
Onik G, Cobb C, Cohen J, et al. US characteristics of frozen prostate. Radiology 1988;168:629–631.
Cohen J, Miller R. Thermal protection of urethra during cryosurgery of prostate. Cryobiology 1994;31:313–316.
Zisman A, Pantuck A, Cohen J. Prostate cryoablation using direct transperineal placement of ultrathin probes through a 17-gauge brachytherapy template: technique and preliminary results. Urology 2001;58:988–993.
Han K, Cohen J, Miller R, et al. Treatment of organ-confined prostate cancer with 3rd generation cryosurgery: preliminary multi-center experience. J Urol 2003;170:1126–1130.
Long J, Bahn D, Lee F, et al. Five-year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate. Urology 2001;57:518–523.
Bahn D, Lee F, Badalament R, et al. Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology 2002;60(2 Suppl 1):3–11.
Pisters L, von Eschenbach A, Scott S, et al. The efficacy and complications of salvage cryotherapy of the prostate. J Urol 1997;157:921–925.
Donnelly B, Saliken J, Ernst D, et al. Prospective trial of cryosurgical ablation of the prostate: five-year results. Urology 2002;60:645–649.
Onik G, Narayan P, Vaughan D, et al. Focal “nerve-sparing” cryosurgery for treatment of primary prostate cancer: a new approach to preserving potency. Urology 2002;60:109–114.
Ghafar M, Johnson C, De La Taille A, et al. Salvage cryotherapy using an argon based system for locally recurrent prostate cancer after radiation therapy: the Columbia experience. J Urol 2001;166:1333–1338.
Chin J, Pautler S, Mouraviev V, et al. Results of salvage cryoablation of the prostate after radiation: identifying predictors of treatment failure and complications. J Urol 2001;165:1937–1942.
Wieder J, Schmidt JD, Casola G, et al. Transrectal ultrasound-guided transperineal cryoablation in the treatment of prostate carcinoma: preliminary results. J Urol 1995;154:435–441.
Long J, Fallick M, LaRock D, et al. Preliminary outcomes following cryosurgical ablation of the prostate in patients with clinically localized prostate carcinoma. J Urol 1998;159:477–484.
Aus G, Bergdahl S, Hugosson J, et al. Stone formation in the prostatic urethra after cryotherapy for prostate cancer. Urology 1997;50:615–617.
Seigne J, Pisters L, von Eschenbach AC. Osteitis pubis as a complication of prostate cryotherapy. J Urol 1996;156:182.
Rukstalis D, Khorsandi M, Garcia F, et al. Clinical experience with open renal cryoablation. Urology 2001;57:34–39.
Delworth M, Pisters L, Fornage B, et al. Cryotherapy for renal cell carcinoma and angiomyolipoma. J Urol 1996;155:252–255.
Rodriguez R, Chan D, Bishoff J, et al. Renal ablative cryosurgery in selected patients with peripheral renal masses. Urology 2000;55:25–30.
Gill I, Novick A, Meraney A, et al. Laparoscopic renal cryoablation in 32 patients. Urology 2000;56:748–753.
Nadler R, Kim S, Rubenstein J, et al. Laparoscopic renal cryosurgery: the Northwestern experience. J Urol 2003;170:1121–1125.
Lee D, McGinnis D, Feld R, et al. Retroperitoneal laparoscopic cryoablation of small renal tumors: intermediate results. Urology 2003;61:83–88.
Shingleton W, Sewell P. Percutaneous renal tumor cryoablation with magnetic resonance image guidance. J Urol 2001;165:773–776.
Chosy S, Nakada S, Lee F, et al. Monitoring renal cryosurgery: predictors of tissue necrosis in swine. J Urol 1998;159:1370–1374.
Sung G, Gill I, Hsu T, et al. Effect of intentional cryoinjury to the renal collecting system. J Endourol 1999;13(S1):A14.
Vogl T, Straub R, Eichler K, et al. Malignant liver tumor treated with MR imaging-guided laser-induced thermotherapy: experience with complications in 899 patients (2520 lesions). Radiology 2002;225:367–377.
Giorgio A, Tarantino L, de Stefano G, et al. Interstitial laser photocoagulation under ultrasound guidance of liver tumors: results in 104 treated patients. Eur J Ultrasound 2000;11:181–188.
Gilliams A, Lees W. Survival after percutaneous, image-guided, thermal ablation of hepatic metastases from colorectal cancer. Dis Colon Rectum 2000;43:656–661.
Tranberg K, Moller P, Hannesson P, et al. Interstitial laser treatment of malignant tumors: initial experience. Eur J Surg Oncol 1996;22:47–54.
Christophi C, Muralidharan V. Chronic liver diseases: epidemiology, pathophysiology, diagnosis and treatment. J Gastroenterol Hepatol 2001;16:548–552.
Dong B, Liang P, Yu X, et al. Percutaneous sonographically guided microwave coagulation therapy for hepatocellular carcinoma: results in 234 patients. AJR Am J Roentgenol 2003;180:1547–1555.
Liang P, Dong B, Yu X, et al. Prognostic factors for percutaneous microwave coagulation therapy of hepatic metastases. AJR Am J Roentgenol 2003;181:1319–1325.
Mitsuzaki K, Yamashita Y, Nishiharu T, et al. CT appearance of hepatic tumors after microwave coagulation therapy. AJR Am J Roentgenol 1998;171:1397–1403.
Yamanaka N, Tanaka T, Oriyama T, et al. Microwave coagulonecrotic therapy for hepatocellular carcinoma. World J Surg 1996;20:1076–1081.
Abe T, Shinzawa H, Wakabayashi H, et al. Value of laparoscopic microwave coagulation therapy for hepatocellular carcinoma in relation to tumor size and location. Endoscopy 2000;32:598–603.
Shibata T, Iimuro Y, Yamamoto Y, et al. Small hepatocellular carcinoma: comparison of radiofrequency ablation and percutaneous microwave coagulation therapy. Radiology 2002;223:331–337.
Sato M, Tokui K, Watanabe Y, et al. Generalized intraperitoneal seeding of hepatocellular carcinoma after microwave coagulation therapy: a case report. Hepato-Gastroenterol 1999;46:2561–2564.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
Cheung, L., Livraghi, T., Solbiati, L., Dodd, G.D., vanSonnenberg, E. (2005). Complications of Tumor Ablation. In: vanSonnenberg, E., McMullen, W.N., Solbiati, L., Livraghi, T., Müeller, P.R., Silverman, S.G. (eds) Tumor Ablation. Springer, New York, NY. https://doi.org/10.1007/0-387-28674-8_37
Download citation
DOI: https://doi.org/10.1007/0-387-28674-8_37
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-95539-1
Online ISBN: 978-0-387-28674-7
eBook Packages: MedicineMedicine (R0)